Interleukin-2 (IL-2) as a consolidative treatment after autologous bone marrow transplantation for hematologic malignancies.

被引：0
|
作者：
Massumoto, C [1 ]
Ostronoff, M [1 ]
Macedo, MCMA [1 ]
ZAmbon, E [1 ]
Medeiros, RSS [1 ]
DorlhiacLlacer, PE [1 ]
Chamone, DAF [1 ]
Dulley, F [1 ]
机构：
[1] UNIV SAO PAULO,HEMOCTR SAO PAULO,FDN PRO SANGUE,BR-05508 SAO PAULO,BRAZIL
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3817 / 3817
页数：1
相关论文
共 50 条
  • [21] AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN HEMATOLOGIC MALIGNANCIES
    MARMONT, AM
    CARELLA, AM
    HAEMATOLOGICA, 1986, 71 (01) : 1 - 12
  • [22] INTERLEUKIN-2 INFUSION AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION ENHANCES HEMATOPOIETIC REGENERATION
    HESLOP, HE
    DUNCOMBE, AS
    REITTIE, JE
    BELLOFERNANDEZ, C
    GOTTLIEB, DJ
    PRENTICE, HG
    HOFFBRAND, AV
    BRENNER, MK
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 1704 - 1705
  • [23] Interleukin-2 before and/or after autologous bone marrow transplantation for pediatric acute leukemia patients
    Messina, C
    Zambello, R
    Rossetti, F
    Gazzola, MV
    Varotto, S
    Destro, R
    Basso, G
    Semenzato, G
    Zanesco, L
    BONE MARROW TRANSPLANTATION, 1996, 17 (05) : 729 - 735
  • [24] BUSULFAN PLUS MELPHALAN (BU/MEL) FOLLOWED BY INTERLEUKIN-2 (IL-2) IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA (AML)
    MASSUMOTO, C
    OSTRONOFF, M
    ZAMBON, E
    ALMEIDA, MC
    BOEHRINGER, B
    CHAMONE, D
    DULLEY, F
    BLOOD, 1994, 84 (10) : A714 - A714
  • [25] Autologous transplantation of interleukin-2 gene transduced bone marrow in a preclinical model
    Kühr, T
    Bechter, O
    Geley, S
    Dietrich, H
    Dirnhofer, S
    Eisterer, W
    Url, M
    Hilbe, W
    Lukas, P
    Thaler, J
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 772 - 772
  • [26] PHASE-I TRIAL OF AN INTERLEUKIN-2 (IL-2) FUSION TOXIN (DAB486IL-2) IN HEMATOLOGIC MALIGNANCIES EXPRESSING THE IL-2 RECEPTOR
    LEMAISTRE, CF
    MENEGHETTI, C
    ROSENBLUM, M
    REUBEN, J
    PARKER, K
    SHAW, J
    DEISSEROTH, A
    WOODWORTH, T
    PARKINSON, DR
    BLOOD, 1992, 79 (10) : 2547 - 2554
  • [27] INTERLEUKIN-2 IN THERAPY OF HEMATOLOGIC MALIGNANCIES
    SZNOL, M
    PARKINSON, DR
    BLOOD, 1994, 83 (08) : 2020 - 2022
  • [28] Differential effects of IL-2 incubation on hematopoietic potential of autologous bone marrow and mobilized PBSC from patients with hematologic malignancies
    Areman, EM
    Rhodes, PL
    Mazumder, A
    Meehan, KR
    JOURNAL OF HEMATOTHERAPY, 1999, 8 (01): : 39 - 44
  • [29] Treatment with low dose IL-2 after autologous bone marrow transplantation (ABMT) for acute myeloid leukemia (AML)
    Falkenburg, JHF
    Schaafsma, MR
    Smith, WM
    KluinNelemans, JC
    HooftmandenOtter, A
    Rijnbeek, M
    vandeMarel, A
    Schellekens, M
    Brandely, M
    Fibbe, WE
    Willemze, R
    BLOOD, 1995, 86 (10) : 2252 - 2252
  • [30] Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy
    Massumoto, C
    Benyunes, MC
    Sale, G
    Beauchamp, M
    York, A
    Thompson, JA
    Buckner, CD
    Fefer, A
    BONE MARROW TRANSPLANTATION, 1996, 17 (03) : 351 - 356
12345